NCT03009721View on ClinicalTrials.gov

Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia

UnknownOBSERVATIONAL
Enrollment

9,707

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
HypertensionDyslipidemias
Interventions
DRUG

Other: Not applicable-observational study

Trial Locations (1)

Unknown

RECRUITING

Dongguk Ilsan University Hospital, Ilsan

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY